Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:54 AM EDT
10.48quote price arrow down-0.01 (-0.10%)
Volume
456
Close
10.49quote price arrow up+0.63 (+6.39%)
Volume
6,272,185
52 week range
5.57 - 10.49
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.49
  • 52 Week High10.49
  • 52 Week High Date03/27/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap3.787B
  • Shares Out360.99M
  • 10 Day Average Volume1.57M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change30.8

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.49
  • 52 Week High10.49
  • 52 Week High Date03/27/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23
  • Market Cap3.787B
  • Shares Out360.99M
  • 10 Day Average Volume1.57M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change30.8

RATIOS/PROFITABILITY

  • EPS (TTM)-1.62
  • P/E (TTM)-6.46
  • Fwd P/E (NTM)2.68
  • EBITDA (TTM)2.863B
  • ROE (TTM)-441.96%
  • Revenue (TTM)8.757B
  • Gross Margin (TTM)70.78%
  • Net Margin (TTM)-6.98%
  • Debt To Equity (MRQ)-2,190.61%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date05/18/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Related Video

Thursday, Feb. 22, 2024: The Investing Club breaks down the big earnings win from this chip holding
VIDEO10:3410:34
Thursday, Feb. 22, 2024: The Investing Club breaks down the big earnings win from this chip holding

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
BHC
Bausch Health Companies Inc
10.49+0.63+6.39%
GUD
CPH
HLS
RX
Biosyent Inc
8.70UNCHUNCH